Ishige-machi, Japan

Hiromi Yoshida



Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Ishige-machi, JP (2006 - 2007)
  • Ibaraki, JP (2007)
  • Tsukuba, JP (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hiromi Yoshida

Introduction

Hiromi Yoshida, hailing from Ishige-machi, Japan, is a prominent inventor known for her contributions to pharmaceutical innovations. With a portfolio of four patents, she has made significant strides in the field of medicinal chemistry, particularly in the development of receptor-binding assays and novel ligand applications.

Latest Patents

One of Yoshida's latest inventions involves FPRL1 ligands and their applications. This invention entails the use of FPRL1 ligands that share a similar amino acid sequence with designated sequences (SEQ ID NO: 1, SEQ ID NO: 17, or SEQ ID NO: 21) which facilitates effective screening for FPRL1 agonists or antagonists. Another significant patent involves a ligand of G protein-coupled receptor protein and its associated DNA. This GPR7 ligand, resembling a specific amino acid sequence with the option for bromination at the N-terminal, proves invaluable in developing a receptor-binding assay system. This system aids in screening candidate compounds for pharmaceutical applications, including drug development targeting obesity.

Career Highlights

Yoshida currently works with Takeda Pharmaceutical Company Limited, a leading entity in the global pharmaceutical industry. Her work focuses on combining innovative research with practical applications to enhance drug discovery and development processes. Through her work in this esteemed company, she has solidified her reputation as a leading figure in medical research.

Collaborations

Throughout her career, Hiromi Yoshida has collaborated with esteemed colleagues including Shuji Hinuma and Yugo Habata. These partnerships have greatly enriched her research endeavors, leading to fruitful projects that leverage collective expertise in pharmaceuticals.

Conclusion

In conclusion, Hiromi Yoshida represents a powerful force in the realm of pharmaceuticals, with significant patents that highlight her innovative spirit and dedication to improving healthcare. Her work not only contributes to the understanding of G protein-coupled receptors but also paves the way for new therapeutic possibilities in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…